Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01741532Phase 3Completed
Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)
Pantothenate Kinase-Associated Neurodegeneration
PrincipalinvestigatorStart date: 2012-12-13

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Friedrich-Baur-Institute, Department of Neurology, University of Munich Ziemssenstr

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

9 similar investigators found

Penelope Hogarth, M.D.

Oregon Health and Science University

Moderately Similar
2 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration
Similarity Score30%

Thomas Klopstock, Prof. Dr.

LMU Klinikum, Friedrich-Baur-Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration
Similarity Score30%

Patrick Chinnery, MD

Newcastle University Institute of Human Genetics

Moderately Similar
1 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Worked with same sponsors:

ApoPharma
Similarity Score30%

Thomas Klopstock, MD

LMU Klinikum

Moderately Similar
2 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Worked with same sponsors:

ApoPharma
Similarity Score30%

Elliott Vichinsky, MD

UCSF Benioff Children's Hospital Oakland

Moderately Similar
5 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Worked with same sponsors:

ApoPharma
Similarity Score30%

Nardo Nardocci, MD

Foundation Neurological Institute C. Besta

Moderately Similar
1 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Worked with same sponsors:

ApoPharma
Similarity Score30%

Susan J Hayflick, MD

Oregon Health and Science University

Moderately Similar
3 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration
Similarity Score30%

Elliott Vichinsky, MD

Children's Hospital & Research Center at Oakland Hematology/ Oncology, Pediatric Rehabilitation

Related
1 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Worked with same sponsors:

ApoPharmaFood and Drug Administration (FDA)
Collaborated on 1 trial
Similarity Score14%

Fernando Tricta, MD

ApoPharma Inc.

Related
3 trials

Shared therapeutic areas:

Pantothenate Kinase-Associated Neurodegeneration

Worked with same sponsors:

ApoPharmaFood and Drug Administration (FDA)
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01741532Phase 3PrincipalInvestigator

Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)

Pantothenate Kinase-Associated Neurodegeneration
Completed

All 1 trials loaded